알림
뒤로

보도자료

회사뉴스 게시판

빅씽크, 美 청소년 우울증 디지털 치료제 국내 독점 계약 체결

회사뉴스
2022-05-24
조회수 2583



https://www.mdtoday.co.kr/news/view/1065592120885334

0
Meagan2025-12-11 01:12
You'll Never Be Able To Figure Out This Louisiana Asbestos Lawyer's Benefits Louisiana Asbestos Lawyer https://pad.stuve.de/tdk4ZKYbTMyCeXM72yPmlQ/
댓글 수정지우기
Courtney Carmack2025-12-11 23:03
How Much Do Goethe Certificate B1 Purchase Experts Make? B1 Goethe-Zertifikat Online Kaufen https://bookmarkhard.com/story20693874/a-brief-history-of-authentic-b1-goethe-exam-history-of-authentic-b1-goethe-exam
댓글 수정지우기
HER2 양성 조기 유방암 치료에 '너링스'가 갖는 의미는? Blue Note Therapeutics and Bixink Enter Licensing Agreement for attune™ and DreAMLand™, Prescription Digital Therapeutics for Mental Well-Being in Cancer Patients
목록

Copyright 2020 - BIXINK    |    Terms of Use    |    Contact

서울특별시 강남구 논현로 561 6층 [06125]

6F, 561 Nonhyeon-ro, Gangnam-gu, Seoul 06125, Republic of Korea